Abstract 4145513: Substrate Characterization and Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients with Non-Ischemic Dilated Cardiomyopathy and Isolated Apical Scar
Background: Patients with non-ischemic dilated cardiomyopathy (NIDCM) and ventricular tachycardia (VT) typically have a basal perivalvular substrate with predominant antero-septal or infero-lateral distribution. Isolated apical substrate responsible for VT in NIDCM has not been previously characterized. Objectives: The purpose of this study is to characterize the prevalence, characteristics and catheter ablation outcomes of NIDCM with isolated apical VT substrate. Methods: Patients with NIDCM and VT from an isolated apical scar were identified from a prospective registry of consecutive patients with NIDCM undergoing VT ablation between 2018 and 2023. Isolated apical scar was defined as apical abnormal bipolar low voltage area (LVA, <1.5 mV for the endocardium, <1.0 mV for the epicardium with abnormal electrograms) demonstrated to participate in VT with activation, entrainment and/or pace mapping in the absence of abnormal electroanatomic substrate in other LV segments. Patients with hypertrophic cardiomyopathy were excluded. Results: Out of 208 patients with NIDCM and VT undergoing catheter ablation during the study period, 5 (2.4%; age 52±10 years, LVEF 37±12%) had isolated apical substrate and underwent a total of 8 ablation procedures (2 endocardial, 6 endo-epicardial). One patient had isolated apical scar on pre-procedural cardiac MRI. All patients had both endocardial and epicardial scar identified. At the end of the procedure, non-inducibility of any VTs was achieved in all cases. After a median follow-up of 11 months (range 6-14 months) after the last procedure, there were no deaths and all patients remained free from recurrent VT. Conclusion: In patients with NIDCM, isolated apical VT substrate is rare. Endo-epicardial catheter ablation is typically needed in these patients and is associated with good VT control over follow-up.
Authors
- Thomas Dresing (ORCID: https://orcid.org/0000-0002-6711-7284)
- Mohamed Kanj
- Shady Nakhla (ORCID: https://orcid.org/0000-0002-4495-3845)
- Yi Wen Becky Liao
- Tyler L. Taigen (ORCID: https://orcid.org/0000-0002-1258-8118)
- Thomas Callahan (ORCID: https://orcid.org/0000-0001-5281-7598)
- Walid I. Saliba (ORCID: https://orcid.org/0000-0003-3324-8611)
- Niraj Varma (ORCID: https://orcid.org/0000-0003-2296-2596)
- Jakub Sroubek (ORCID: https://orcid.org/0000-0003-2490-5106)
- Ayman A. Hussein (ORCID: https://orcid.org/0000-0002-8359-1525)
- Pasquale Santangeli (ORCID: https://orcid.org/0000-0002-0023-9666)
- Bryan Baranowski
- Robert Koeth (ORCID: https://orcid.org/0009-0003-1673-2193)
- Arshneel Kochar (ORCID: https://orcid.org/0000-0002-8010-7750)
- Mandeep Bhargava (ORCID: https://orcid.org/0000-0002-8287-8014)
- Oussama M. Wazni (ORCID: https://orcid.org/0000-0001-7115-7716)
- Jeff Courson
- Kenneth A. Mayuga (ORCID: https://orcid.org/0000-0002-3434-9599)
- Koji Higuchi (ORCID: https://orcid.org/0000-0002-9218-1966)
- Nolan Hight
- Justin Lee (ORCID: https://orcid.org/0000-0003-2444-0169)
- Mina K. Chung
- John Rickard (ORCID: https://orcid.org/0000-0002-1559-0803)
- David Martín (ORCID: https://orcid.org/0009-0004-1020-2834)
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Circulation
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1161/circ.150.suppl_1.4145513
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00